Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,724 public trials 629 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Completed

A Study of Lanadelumab (Takhzyro) and Icatibant (Firazyr®) in Persons With HAE in China

NCT06346899

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • The First Affiliated Hospital of Fujian Medical University Fuzhou, Fujan, China
  • The First Affiliated Hospital ,Sun Yat-sen University Guangzhou, Guangdong, China
  • The Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
  • Henan Provincial People's Hospital Zhengzhou, Henan, China
View all 13 locations
View Trial Details
Completed

Patient Characteristics, Treatment Patterns and Outcomes of Patients With Severe Asthma Treated With Tezepelumab in the Real World; a Retrospective, Observational Medical Chart Review Conducted in UK Severe Asthma Centres

NCT06455462

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +7 more
Locations
  • Research Site Birmingham, United Kingdom
  • Research Site Liverpool, United Kingdom
  • Research Site London, United Kingdom
  • Research Site Newcastle, United Kingdom
View Trial Details
Completed

A Study to Evaluate Bioavailability of Rocatinlimab Autoinjector and Vial in Healthy Participants

NCT06438263

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Fortrea Clinical Research Unit - Daytona Beach Daytona Beach, Florida, United States
  • Fortrea Clinical Research Unit - Dallas Dallas, Texas, United States
  • Fortrea Clinical Research Unit Inc. - Madison Madison, Wisconsin, United States
View Trial Details
Completed

Asthma in Pregnancy

NCT05047419

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +7 more
Locations
  • University of Iowa Hospitals & Clinics Iowa City, Iowa, United States
View Trial Details
Completed

A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

NCT05704738

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Cahaba Dermatology and Skin Health Center Birmingham, Alabama, United States
  • AllerVie Clinical Research- Cullman Cullman, Alabama, United States
  • Eclipse Clinical Research Tucson, Arizona, United States
  • Arkansas Research Trials, LLC North Little Rock, Arkansas, United States
View all 246 locations
View Trial Details

Related conditions